维普中文期刊产品整合服务
13篇 您的检索式:作者名="INDU B"
    题名 作者 年代 出处 被引量
1Absorption and migration of bio-based epoxidized soybean oil and its mixtures with tri(2-2ethylhexyl)trimellitate in poly(vinylchloride)显示文摘Di M Indu C B Bin S 2001Journal of Applied Polymer Science2001,26,7:1
2An alternative improved method for the homogeneous dispersion of CNTs in Cu matrix for the fabrication of Cu/CNTs composites显示文摘Maneet La S.K Singhal Indu Sharma R B Mathur 0,,03:1
3Lipase enzyme immobilization on synthetic beaded macroporous copolymers for kinetic resolution of chiral drugs intermediates显示文摘 RAJINDER P GULAM NQ 2008Process Biochemistry2008,43,4:1
4Enhanced power generation from PV array under parital shading conditions by shade dispersion using So Do Ku configuration 显示文摘B Indu Rani G Saravana Ilango Chilakapati Naga- mani 2013IEEE Transactions on Sustain- able energy2013,4,3:1
5Current therapies and novel approaches for biliary diseases显示文摘Chronic liver diseases that inevitably lead to hepatic fibrosis, cirrhosis and/or hepatocellular carcinoma have become a major cause of illness and death worldwide. Among them, cholangiopathies or cholestatic liver diseases comprise a large group of conditions in which injury is primarily focused on the biliary system. These include congenital diseases(such as biliary atresia and cystic fibrosis), acquired diseases(such as primary sclerosing cholangitis and primary biliary cirrhosis), and those that arise from secondary damage to the biliary tree from obstruction, cholangitis or ischaemia. These conditions are associated with a specific pattern of chronic liver injury centered on damaged bile ducts that drive the development of peribiliary fibrosis and, ultimately, biliary cirrhosis and liver failure. For most, there is no established medical therapy and, hence, these diseases remain one of the most important indications for liver transplantation.As a result, there is a major need to develop new therapies that can prevent the development of chronic biliary injury and fibrosis. This mini-review briefly discusses the pathophysiology of liver fibrosis and its progression to cirrhosis.We make a special emphasis on biliary fibrosis and current therapeutic options,such as angiotensin converting enzyme-2(known as ACE2) over-expression in the diseased liver as a novel potential therapy to treat this condition.Indu G Rajapaksha Peter W Angus Chandana B Herath 2019World Journal of Gastrointestinal Pathophysiology2019,10,1:1
6Control strategy for power flow management in a PV system supplying DC loads显示文摘Indu Rani B Saravana Ilango G Nagamani C 2013IEEE Transactions on Industrial Electronics2013,60,8:1
7PLGA nanoparticles in drug delivery: the state of the art 显示文摘Indu B Sarita H MNV R K 2004Crit Rev Therapeut Drug Car Sys2004,21,5:1
8Lipase enzyme immobilizationon synthetic beaded macroporous copolymers for kinetic resolutionof chiral drugs intermediates 显示文摘Indu B Rajinder P GuIam N Q 2008Process Biochemistry2008,43,:1
9PLGA nanoparticles in drug delivery:the state of the art显示文摘INDU B SARITA H MNV R K 2004Crit Rev Therapeut Drug Car Sys2004,21,5:1
10In vitro catabolism of rutin by human fecal bacteria and the antioxidant capacity of its catabolites 显示文摘Indu B J William M Michael E J 2009Free Radic Biol Med2009,47,8:1
11PLGA nanoparticles in drug delivery: the state of the art显示文摘Indu B Sarita H Mnvr K 2004Crit Rev Therapeut Drug Car Sys2004,21,5:1
12Highly flexible piezoelectric 0 3 PZT- PDMS composites with high filler content 显示文摘Indu B Gijsbertus D W 2014Compos Sci Techno2014,91,2:1
13PLGA nanoparticles in drug delivery: the state of the art显示文摘INDU B SARITA H 2004Ther Drug Car Syst2004,21,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费